vs
Side-by-side financial comparison of NATIONAL BANKSHARES INC (NKSH) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
NATIONAL BANKSHARES INC is the larger business by last-quarter revenue ($15.3M vs $12.6M, roughly 1.2× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 38.5%, a 212.2% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 24.7%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs 20.9%).
Nicolet Bankshares, Inc. is a U.S. regional bank holding company based in Green Bay, Wisconsin. They are the parent company of Nicolet National Bank, the second largest Wisconsin-based bank.
NKSH vs SPRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $15.3M | $12.6M |
| Net Profit | $5.9M | $31.5M |
| Gross Margin | — | — |
| Operating Margin | 47.4% | — |
| Net Margin | 38.5% | 250.7% |
| Revenue YoY | 24.7% | 24080.8% |
| Net Profit YoY | 91.0% | 250.9% |
| EPS (diluted) | $0.93 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $15.3M | $12.6M | ||
| Q3 25 | $14.2M | $0 | ||
| Q2 25 | $13.3M | $0 | ||
| Q1 25 | $12.8M | $12.0K | ||
| Q4 24 | $12.2M | $52.0K | ||
| Q3 24 | $11.7M | $65.0K | ||
| Q2 24 | $10.9M | $114.0K | ||
| Q1 24 | $10.4M | $140.0K |
| Q4 25 | $5.9M | $31.5M | ||
| Q3 25 | $4.4M | $-7.4M | ||
| Q2 25 | $2.3M | $-1.7M | ||
| Q1 25 | $3.2M | $-13.9M | ||
| Q4 24 | $3.1M | — | ||
| Q3 24 | $2.7M | $-17.1M | ||
| Q2 24 | $-307.0K | $-17.9M | ||
| Q1 24 | $2.2M | $-12.7M |
| Q4 25 | 47.4% | — | ||
| Q3 25 | 37.9% | — | ||
| Q2 25 | 20.0% | — | ||
| Q1 25 | 30.5% | -122758.3% | ||
| Q4 24 | 30.1% | — | ||
| Q3 24 | 27.5% | -28604.6% | ||
| Q2 24 | -4.4% | -16720.2% | ||
| Q1 24 | 25.8% | -9987.1% |
| Q4 25 | 38.5% | 250.7% | ||
| Q3 25 | 31.1% | — | ||
| Q2 25 | 17.2% | — | ||
| Q1 25 | 25.3% | -115550.0% | ||
| Q4 24 | 25.1% | — | ||
| Q3 24 | 22.8% | -26380.0% | ||
| Q2 24 | -2.8% | -15668.4% | ||
| Q1 24 | 20.8% | -9049.3% |
| Q4 25 | $0.93 | $0.56 | ||
| Q3 25 | $0.69 | $-0.13 | ||
| Q2 25 | $0.36 | $-0.03 | ||
| Q1 25 | $0.51 | $-0.25 | ||
| Q4 24 | $0.50 | — | ||
| Q3 24 | $0.42 | $-0.32 | ||
| Q2 24 | $-0.05 | $-0.33 | ||
| Q1 24 | $0.37 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $59.3M | $40.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $184.9M | $59.0M |
| Total Assets | $1.8B | $68.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $59.3M | $40.3M | ||
| Q3 25 | $42.3M | $48.6M | ||
| Q2 25 | $92.8M | $31.2M | ||
| Q1 25 | $122.5M | $48.9M | ||
| Q4 24 | $108.1M | $52.9M | ||
| Q3 24 | $49.8M | $76.3M | ||
| Q2 24 | $98.9M | $63.5M | ||
| Q1 24 | $121.2M | $82.3M |
| Q4 25 | $184.9M | $59.0M | ||
| Q3 25 | $179.2M | $26.5M | ||
| Q2 25 | $168.7M | $32.8M | ||
| Q1 25 | $167.3M | $33.8M | ||
| Q4 24 | $156.4M | $46.1M | ||
| Q3 24 | $167.8M | $65.5M | ||
| Q2 24 | $149.0M | $80.5M | ||
| Q1 24 | $139.4M | $96.2M |
| Q4 25 | $1.8B | $68.9M | ||
| Q3 25 | $1.8B | $54.2M | ||
| Q2 25 | $1.8B | $62.1M | ||
| Q1 25 | $1.8B | $77.7M | ||
| Q4 24 | $1.8B | $110.5M | ||
| Q3 24 | $1.8B | $135.2M | ||
| Q2 24 | $1.8B | $149.9M | ||
| Q1 24 | $1.7B | $167.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $17.9M | $-8.4M |
| Free Cash FlowOCF − Capex | $15.2M | — |
| FCF MarginFCF / Revenue | 99.2% | — |
| Capex IntensityCapex / Revenue | 17.9% | — |
| Cash ConversionOCF / Net Profit | 3.04× | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | $23.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $17.9M | $-8.4M | ||
| Q3 25 | $6.1M | $17.4M | ||
| Q2 25 | $2.1M | $-17.7M | ||
| Q1 25 | $2.6M | $-4.0M | ||
| Q4 24 | $9.4M | $-23.4M | ||
| Q3 24 | $3.1M | $12.8M | ||
| Q2 24 | $-3.0M | $-18.7M | ||
| Q1 24 | $3.8M | $5.9M |
| Q4 25 | $15.2M | — | ||
| Q3 25 | $5.3M | — | ||
| Q2 25 | $1.5M | — | ||
| Q1 25 | $1.6M | — | ||
| Q4 24 | $6.2M | — | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $-4.0M | — | ||
| Q1 24 | $3.5M | — |
| Q4 25 | 99.2% | — | ||
| Q3 25 | 37.4% | — | ||
| Q2 25 | 11.5% | — | ||
| Q1 25 | 12.5% | — | ||
| Q4 24 | 50.5% | — | ||
| Q3 24 | 18.5% | — | ||
| Q2 24 | -36.3% | — | ||
| Q1 24 | 33.8% | — |
| Q4 25 | 17.9% | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | 4.1% | — | ||
| Q1 25 | 7.5% | — | ||
| Q4 24 | 26.6% | — | ||
| Q3 24 | 8.3% | — | ||
| Q2 24 | 9.3% | — | ||
| Q1 24 | 3.0% | — |
| Q4 25 | 3.04× | -0.26× | ||
| Q3 25 | 1.38× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | 0.79× | — | ||
| Q4 24 | 3.07× | — | ||
| Q3 24 | 1.17× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.77× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
